Central venous catheters play a major role in modern healthcare, as they allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as provide hemodialysis access and hemodynamic monitoring.
The global central venous catheter market size was valued at US$ 1,167.4 million in 2017, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).
Get PDF Brochure for Research Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2400
Increasing prevalence of cancer and renal diseases is expected to propel growth of central venous catheter market
Central venous catheterization is used for chemotherapy administration, total parenteral nutrition, administration of intravenous fluids, administration of blood and platelet transfusions, and other uses. High prevalence of cancer is expected to propel demand for central venous catheterization, which in turn is expected to drive the market growth. According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012 and in 2015, cancer was responsible for 8.8 million deaths worldwide. Moreover, WHO stated that the number of new cases is expected to rise by around 70% by 2030.
Similarly, according to the study by University of California, 2014, around 2 million people worldwide are affected by end stage renal disease (ESRD) and the number of patients diagnosed with the disease is expected to increase at a rate of 5-7% annually.
Increasing adoption of central venous catheters in North America is expected to bolster the market growth
North America holds dominant position in the global central venous catheter market, owing to high availability of catheters in medical settings. According to the survey by PavMed, 2016, around 7 million central vascular access devices are utilized annually in the U.S., which includes 400-500,000 implantable ports. Increasing prevalence of cancer in the region is also expected to boost the market growth. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.
Moreover, increase in central venous infections is expected to enhance demand for novel antimicrobial catheters, thereby reducing economic burden caused due to hospitalization. For instance, according to the Cincinnati Children’s Hospital Medical Center, 2014, around 250,000 central venous catheter infections occur annually, procuring the total cost of US$ 7.5- 11 Bn annually to the U.S. healthcare system.
Major players operating in the global central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.
Global Central Venous Catheter Market, By Product Type:
• Peripherally Inserted Central Catheters (PICC)
• Implantable Ports
• Tunneled Central Venous Catheter
• Non-tunneled Central Venous Catheter
Global Central Venous Catheter Market, By Design:
• Single Lumen
• Double Lumen
• Multiple Lumen
Global Central Venous Catheter Market, By Composition:
Get Full Access of This Business Report: https://www.coherentmarketinsights.com/market-insight/central-venous-catheter-market-2400
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]